- People
- Practices
- Antitrust/Competition
- International Practice
- Broker-Dealer and Market Regulation
- Labor and Employment
- Climate Change
- Litigation
- Corporate and Securities
- Private Client Services
- Educational Institutions
- Private Investment Funds
- Energy
- Public Finance
- Environmental Strategies
- Real Estate and Projects
- Finance
- Securities Regulation
- Financial Institutions
- Strategic Communications
- Financial Restructuring
- Tax
- Government
- Technology
- Intellectual Property
- White Collar Defense
- Internal Investigations
- News & Publications
- Rankings & Awards
- Events
- Blogs
Technology

Bracewell & Giuliani helps clients develop, protect and deploy innovative technologies in telecommunications, electronics, Internet and e-commerce, software, interactive entertainment, energy, biotechnology, nanotechnology, and other industries around the world. We provide strategic business, legal and governmental counsel to technology businesses at every stage of a company's business life — from initial creation and protection of ideas, through development of strong businesses and establishment of market leadership, to mergers, acquisitions and other strategic transactions. We help our clients:
- Navigate government policies and regulation
- License and develop intellectual property
- Raise capital from venture and angel investors
- Identify and pursue government contracting opportunities
- Secure public equity and debt financing
- Merge, acquire and divest assets
- Create joint ventures, alliances and partnerships
- Manage employment and compensation issues
Many of our lawyers have specific industry knowledge and business experience, having been trained in technology-related and scientific disciplines. Working in multidisciplinary teams, we tap the experience of attorneys from the firm’s corporate, securities, tax, intellectual property, environmental, labor and employment, employee benefits, and litigation departments.
Bracewell represents emerging biosciences companies and institutions that develop biosciences technologies such as medical imaging and pharmacology software, biochips, DNA-sequencing tools, wound-care supplies, and drugs to treat Alzheimer's disease, AIDS and cancer. We also work with institutions to structure technology transfer agreements, and represent venture capitalists seeking investment opportunities in companies developing biosciences applications.